Cytokinetics (CYTK) Interest Coverage Ratio Growth (3y) (2016 - 2025)
Powered by 
Analysis
Cytokinetics (CYTK) Interest Coverage Ratio Growth (3y) (2016 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 29.79% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -44.22% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 33.30% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -35.50% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 81.16% |
| 10 | Cytokinetics | 9.63 Bn | 8.46 Bn | 25.89 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 11.46% |
| Sep 30, 2025 | 2.69% |
| Jun 30, 2025 | -37.45% |
| Dec 31, 2024 | -44.60% |
| Sep 30, 2024 | 1.75% |
| Jun 30, 2024 | 8.74% |
| Mar 31, 2024 | -20.40% |
| Dec 31, 2023 | -40.28% |
| Sep 30, 2023 | -171.66% |
| Jun 30, 2023 | -46.83% |
| Mar 31, 2023 | -49.64% |
| Dec 31, 2022 | -61.36% |
| Sep 30, 2022 | -52.47% |
| Jun 30, 2022 | 9.78% |
| Mar 31, 2022 | -32.60% |
| Dec 31, 2021 | -4.37% |
| Sep 30, 2021 | -61.76% |
| Jun 30, 2021 | -35.59% |
| Mar 31, 2021 | -17.18% |
| Dec 31, 2020 | 10.52% |